Apr 1, 2015· Comment submitted by Uni Blake, Scientific Advisor, American Petroleum Institute (API)· EPA-HQ-OPPT-2014-0766-0014
Filed on regulations.gov — full text not in the inline record.
EPANonrulemakingEPA-HQ-OPPT-2014-0766
Final Test Guidelines; Endocrine Disruptor Screening Program Test Guidelines (Series 890); Three Tier 2 Non-Mammalian Tests; Notice of Availability
RIN
—
Last modified
Apr 15, 2022
Comment window
closed 4137d ago
American Petroleum Institute filings
1
Activity
American Petroleum Institute filed 1 comment on this docket between Apr 1, 2015 and Apr 1, 2015. 0 other organizations filed here. The comment window closed 4137d ago.
What American Petroleum Institute filed (1)
Abstract
EPA’s Endocrine Disruptor Screening Program (EDSP) is announcing the availability of final test guidelines for three Tier 2 non-mammalian tests: medaka extended one-generation–reproduction test (MEOGRT), OCSPP 890.2200; larval amphibian growth and development assay (LAGDA), OCSPP 890.2300; and Avian two-generationtoxicity test in Japanese quail (JQTT), OCSPP 890.2100. The EPA announced the availability of the draft test guidelines for public comment in January 2015.
View on regulations.gov →Co-filers (0)
See everyone who commented →- American Petroleum InstituteTHIS ORG1 filing · confidence 97%